Skip to main content
Top
Published in: Pediatric Surgery International 5/2017

01-05-2017 | Review Article

Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease

Authors: J. C. Langer, M. D. Rollins, M. Levitt, A. Gosain, L. de la Torre, R. P. Kapur, R. A. Cowles, J. Horton, D. H. Rothstein, A. M. Goldstein, On behalf of the American Pediatric Surgical Association Hirschsprung Disease Interest Group

Published in: Pediatric Surgery International | Issue 5/2017

Login to get access

Abstract

Although most children with Hirschsprung disease ultimately do well, many experience a variety of ongoing problems after pull-through surgery. The most common include obstructive symptoms, soiling, enterocolitis and failure to thrive. The purpose of this guideline is to present a rational approach to the management of postoperative obstructive symptoms in children with Hirschsprung disease. The American Pediatric Surgical Association Board of Governors established a Hirschsprung Disease Interest Group. Group discussions, literature review and expert consensus were then used to summarize the current state of knowledge regarding causes, methods of diagnosis, and treatment approaches to children with obstructive symptoms following pull-through for Hirschsprung disease. Causes of obstructive symptoms post-pull-through include mechanical obstruction; persistent or acquired aganglionosis, hypoganglionosis, or transition zone pull-through; internal sphincter achalasia; disordered motility in the proximal intestine that contains ganglion cells; or functional megacolon caused by stool-holding behavior. An algorithm for the diagnosis and management of obstructive symptoms after a pull-through for Hirschsprung disease is presented. A stepwise, logical approach to the diagnosis and management of patients experiencing obstructive symptoms following pull-through for Hirschsprung disease can facilitate treatment.
Level of evidence V.
Literature
1.
go back to reference Dasgupta R, Langer JC (2008) Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child. J Pediatr Gastroenterol Nutr 46:13–19CrossRefPubMed Dasgupta R, Langer JC (2008) Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child. J Pediatr Gastroenterol Nutr 46:13–19CrossRefPubMed
2.
go back to reference Langer JC (2004) Persistent obstructive symptoms after surgery for Hirschsprung disease: development of a diagnostic and therapeutic algorithm. J Pediatr Surg 39:1458–1462CrossRefPubMed Langer JC (2004) Persistent obstructive symptoms after surgery for Hirschsprung disease: development of a diagnostic and therapeutic algorithm. J Pediatr Surg 39:1458–1462CrossRefPubMed
3.
go back to reference Mueller CM, Beaunoyer M, St-Vil D (2010) Topical mitomycin-C for the treatment of anal stricture. J Pediatr Surg 45:241–244CrossRefPubMed Mueller CM, Beaunoyer M, St-Vil D (2010) Topical mitomycin-C for the treatment of anal stricture. J Pediatr Surg 45:241–244CrossRefPubMed
4.
go back to reference Pena A, Elicevik M, Levitt MA (2007) Reoperations in Hirschsprung disease. J Pediatr Surg 42:1008–1013CrossRefPubMed Pena A, Elicevik M, Levitt MA (2007) Reoperations in Hirschsprung disease. J Pediatr Surg 42:1008–1013CrossRefPubMed
5.
go back to reference Kapur R (2016) Histology of the transition zone in Hirschsprung disease. Am J Surg Pathol 40:1637–1646CrossRefPubMed Kapur R (2016) Histology of the transition zone in Hirschsprung disease. Am J Surg Pathol 40:1637–1646CrossRefPubMed
6.
go back to reference Patrus B, Nasr A, Langer JC et al (2011) Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease. J Pediatr Surg 46:184–187CrossRefPubMed Patrus B, Nasr A, Langer JC et al (2011) Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease. J Pediatr Surg 46:184–187CrossRefPubMed
7.
go back to reference Zaslavsky C, da Silveira TR, Maguilnik I (1998) Total and segmental colonic transit time with radio-opaque markers in adolescents with functional constipation. J Pediatr Gastroenterol Nutr 27:138–142CrossRefPubMed Zaslavsky C, da Silveira TR, Maguilnik I (1998) Total and segmental colonic transit time with radio-opaque markers in adolescents with functional constipation. J Pediatr Gastroenterol Nutr 27:138–142CrossRefPubMed
8.
go back to reference Southwell BR, Clarke MC, Sutcliffe J et al (2009) Colonic transit studies: Normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int 25:559–572CrossRefPubMed Southwell BR, Clarke MC, Sutcliffe J et al (2009) Colonic transit studies: Normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int 25:559–572CrossRefPubMed
9.
go back to reference Pensabene L, Youssef NN, Griffiths JM, Di Lorenzo C (2003) Colonic manometry in children with defecatory disorders: role in diagnosis and management. Am J Gastroenterol 98:1052–1057PubMed Pensabene L, Youssef NN, Griffiths JM, Di Lorenzo C (2003) Colonic manometry in children with defecatory disorders: role in diagnosis and management. Am J Gastroenterol 98:1052–1057PubMed
Metadata
Title
Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease
Authors
J. C. Langer
M. D. Rollins
M. Levitt
A. Gosain
L. de la Torre
R. P. Kapur
R. A. Cowles
J. Horton
D. H. Rothstein
A. M. Goldstein
On behalf of the American Pediatric Surgical Association Hirschsprung Disease Interest Group
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Surgery International / Issue 5/2017
Print ISSN: 0179-0358
Electronic ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-017-4066-7

Other articles of this Issue 5/2017

Pediatric Surgery International 5/2017 Go to the issue